Screening with fecal immunochemical tests (FITs) lowers the risk of dying from colorectal cancer (CRC), according to a study published online July 19 in JAMA Network Open. Chyke A. Doubeni, M.D., from ...

In DID analysis, the rate of incidence was reduced by 0.34 cases per person-years in the screening group as compared with the historical FIT screening group (rate ratio [RR], 0.08 [95% CI, 0.07 to ...

John Crouchley lost about 5st (32kg) after experiencing digestive problems, before his diagnosis.

Fecal immunochemical testing, which tests for human blood in a patient’s stool, is now available as a take-home test from Life Line Screening, according to a company news release. The test requires no ...

Colorectal cancer (CRC) remains a major global health challenge, with early detection proving essential for effective treatment and improved patient outcomes. Fecal immunochemical testing (FIT) has ...

The move could help to save lives by detecting cases earlier, health bosses say.

A new study found fecal immunochemical testing is more effective than guaiac fecal occult blood testing and is often performed at a lower cost, according to findings published by the Journal of the ...

Please provide your email address to receive an email when new articles are posted on . Annual fecal immunochemical testing was the most effective and cheapest CRC screening method for underserved ...

About The Study: This study found that comparable levels of sensitivity and specificity as reported for the multitarget stool RNA (mt-sRNA) test in the colorectal cancer (CRC)-PREVENT study could be ...

In a new study aimed at identifying the best approach to promote colorectal cancer screening in adults aged 45 to 49, UCLA researchers found that simply mailing a stool-based test directly to people's ...

Fact checked by Nick Blackmer Key Takeaways Cologuard Plus, a new version of the Cologuard colorectal screening test, became ...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech ...